Eiropas Savienība -
zviedru -
EMA (European Medicines Agency)
recarbrio
merck sharp & dohme b.v. - imipenem monohydrat, cilastatin natrium, relebactam monohydrat - gramnegativa bakteriella infektioner - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 och 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 och 5. hänsyn bör tas till officiella riktlinjer för lämplig användning av antibakteriella medel.
Eiropas Savienība -
zviedru -
EMA (European Medicines Agency)
elfabrio
chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry disease - andra matsmältningsorgan och ämnesomsättning produkter, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).
Zviedrija -
zviedru -
Läkemedelsverket (Medical Products Agency)
mixobar colon 1 g/ml oral /rektalsuspension
bracco imaging spa - bariumsulfat - oral /rektalsuspension - 1 g/ml - bariumsulfat 1 g aktiv substans; metylparahydroxibensoat hjälpämne; kaliumsorbat hjälpämne; sorbitol hjälpämne; bensoesyra hjälpämne; sorbinsyra hjälpämne - bariumsulfat
Eiropas Savienība -
zviedru -
EMA (European Medicines Agency)
vaxchora
bavarian nordic a/s - vibrio cholerae, stam cvd-103-hgr, live - kolera - vacciner - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. detta vaccin ska användas i enlighet med officiella rekommendationer.